Erin S. Coyne

机构：Merck & Co., Inc., Rahway, NJ, USA (United States), Merck Institute for Science Education · ORCID：0000-0002-7746-9478

发表论文 10 篇 · 总被引 280 次 · h-index 5

代表论文

• The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation (2016 · American Journal of Physiology-Cell Physiology · 被引 182)
• The deubiquitinating enzyme USP19 modulates adipogenesis and potentiates high-fat-diet-induced obesity and glucose intolerance in mice (2018 · Diabetologia · 被引 38)
• Knockout of USP19 Deubiquitinating Enzyme Prevents Muscle Wasting by Modulating Insulin and Glucocorticoid Signaling (2018 · Endocrinology · 被引 24)
• The business of deubiquitination – location, location, location (2016 · F1000Research · 被引 20)
• Loss of mitochondrial amidoxime-reducing component 1 (mARC1) prevents disease progression by reducing fibrosis in multiple mouse models of chronic liver disease (2025 · Hepatology Communications · 被引 9)
• Loss of low-molecular-weight protein tyrosine phosphatase shows limited improvement in glucose tolerance but causes mild cardiac hypertrophy in mice (2022 · American Journal of Physiology-Endocrinology and Metabolism · 被引 5)